Semaglutide, a medication originally developed for managing type 2 diabetes, has quickly gained widespread recognition for its remarkable benefits beyond diabetes control, including significant weight loss and improvements in heart health. This breakthrough treatment belongs to the GLP-1 receptor agonist class, which works by mimicking the hormone glucagon-like peptide-1 (GLP-1) https://crmforrealestateagents86429.activosblog.com/30260849/semaglutide-a-breakthrough-treatment-for-weight-loss-diabetes-and-cardiovascular-health